In the BYLieve study, the percentage of patients alive without disease progression at 6 months was 50.4%in cohort A (CDK4/6and ET patients who progressed and received fulvestrant-containing apricoxib), the percentage of patients alive and free of disease progression at 6 months was 48.7%. The retail price of the Indian version of the original medicine in pharmacies is about three to four thousand per 150 mg 28 tablets. The retail price of the European version in pharmacies is about 150mg56 tablets4 about 10,000 yuan. If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about high-quality overseas drugs for you.
.jpeg)
